COVID-19 disease. COVID-19 disease
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group, in addition to receiving routine treatment, will use the herbal tea including mallow flower, chicory seeds, sweet violet flower, Melilotus O
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Positive result of PCR or CT SCAN of COVID-19 disease in accordance with international standards Age 60-15 years Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: Has diseases such as Alzheimer's, Parkinson's, multiple sclerosis, neuromuscular diseases, myasthenia gravis Pregnant women Patients with blood pressure lower than 40/90 mmHg Breathe more or equal to 30 per minute Blood oxygen saturation less than 93% at rest PaO2 to FiO2 ratio less than or equal to 300 mmHg Patients with more than 50% of exudative lesions in 24-48 hours in the lung image
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory rate. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation.;Number of coughs. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation.;Percentage of oxygen saturation. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Pulse Oximeter device.;Shortness of breath. Timepoint: Before the intervention and the first to fifth days of treatment. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Akhveh
Esfahan University of Medical Sciences
Outcome results
None listed